Brief: Aldeyra Therapeutics Announces Expansion of RASP Platform
13/11/2025 12:29
Nov 13 (Reuters) - Aldeyra Therapeutics Inc ALDX.O: ALDEYRA THERAPEUTICS ANNOUNCES EXPANSION OF RASP PLATFORM TO INCLUDE CENTRAL NERVOUS SYSTEM DISEASES AND PROVIDES UPDATES ON REPROXALAP AT RESEARCH & DEVELOPMENT WEBCAST Source text: ID:nBw3zyHBba Further company coverage: ALDX.O ((reuters.briefs@thomsonreuters.com;))
Recent news on Aldeyra Therapeutics
See all newsBrief: Aldeyra Therapeutics Announces Intent To Submit Formal Dispute Resolution Request For Reproxalap To Treat Dry Eye Disease
Aldeyra Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Aldeyra Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Aldeyra Therapeutics Pays Off $15 Million Outstanding Borrowings, Terminates Hercules Credit Facility - SEC Filing
U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora